D.A. Kalbhen

658 total citations
48 papers, 494 citations indexed

About

D.A. Kalbhen is a scholar working on Molecular Biology, Rheumatology and Pharmacology. According to data from OpenAlex, D.A. Kalbhen has authored 48 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Rheumatology and 10 papers in Pharmacology. Recurrent topics in D.A. Kalbhen's work include Osteoarthritis Treatment and Mechanisms (15 papers), Inflammatory mediators and NSAID effects (10 papers) and Proteoglycans and glycosaminoglycans research (6 papers). D.A. Kalbhen is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (15 papers), Inflammatory mediators and NSAID effects (10 papers) and Proteoglycans and glycosaminoglycans research (6 papers). D.A. Kalbhen collaborates with scholars based in Germany, Czechia and United States. D.A. Kalbhen's co-authors include R. Domenjoz, Jane Dunham, Jürgen Steinmeyer, Christoph Hiemke, John McClure, M K Jasani, Gerold F. Kauert, T. Sargent, Alexander T. Shulgin and Sabine Daufeldt and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Chromatography A and Life Sciences.

In The Last Decade

D.A. Kalbhen

46 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.A. Kalbhen Germany 13 190 140 140 88 47 48 494
R. Domenjoz Germany 10 64 0.3× 97 0.7× 88 0.6× 42 0.5× 31 0.7× 43 379
Stephen R. Gross United States 15 110 0.6× 377 2.7× 43 0.3× 73 0.8× 21 0.4× 30 692
A. Blackham United Kingdom 11 65 0.3× 69 0.5× 149 1.1× 31 0.4× 36 0.8× 24 346
Lawrence W. Chakrin United Kingdom 14 31 0.2× 196 1.4× 80 0.6× 200 2.3× 95 2.0× 40 618
M. Petríková Slovakia 12 61 0.3× 143 1.0× 53 0.4× 64 0.7× 25 0.5× 36 472
Anne‐Marie Lamhonwah Canada 18 62 0.3× 428 3.1× 26 0.2× 118 1.3× 35 0.7× 25 771
E A Burgess United Kingdom 13 132 0.7× 331 2.4× 19 0.1× 146 1.7× 11 0.2× 25 786
Hiromi Sugimoto Japan 12 34 0.2× 185 1.3× 130 0.9× 186 2.1× 72 1.5× 23 525
Takashi Nose Japan 12 28 0.1× 198 1.4× 69 0.5× 63 0.7× 101 2.1× 59 514
F D Assimacopoulos-Jeannet United States 6 37 0.2× 317 2.3× 45 0.3× 114 1.3× 95 2.0× 6 520

Countries citing papers authored by D.A. Kalbhen

Since Specialization
Citations

This map shows the geographic impact of D.A. Kalbhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.A. Kalbhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.A. Kalbhen more than expected).

Fields of papers citing papers by D.A. Kalbhen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.A. Kalbhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.A. Kalbhen. The network helps show where D.A. Kalbhen may publish in the future.

Co-authorship network of co-authors of D.A. Kalbhen

This figure shows the co-authorship network connecting the top 25 collaborators of D.A. Kalbhen. A scholar is included among the top collaborators of D.A. Kalbhen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.A. Kalbhen. D.A. Kalbhen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steinmeyer, Jürgen, Sabine Daufeldt, & D.A. Kalbhen. (1997). Effects of the Hydroxamic Acid Derivate Ro 31-4724 on the Metabolism and Morphology of lnterleukin-1 -Treated Cartilage Explants. Pharmacology. 55(2). 95–108. 3 indexed citations
2.
Steinmeyer, Jürgen, Sabine Daufeldt, & D.A. Kalbhen. (1997). The proteoglycan metabolism, morphology and viability of articular cartilage treated with a synthetic matrix metalloproteinase inhibitor. Research in Experimental Medicine. 197(2). 63–79. 2 indexed citations
3.
Steinmeyer, Jürgen & D.A. Kalbhen. (1996). The inhibitory effects of antirheumatic drugs on the activity of human leukocyte elastase and cathepsin G. Inflammation Research. 45(7). 324–329. 8 indexed citations
4.
Steinmeyer, Jürgen, Sabine Daufeldt, & D.A. Kalbhen. (1994). Pharmacologic Influence on the Activity of Stromelysin from Bovine Articular Cartilage. Annals of the New York Academy of Sciences. 732(1). 482–483. 6 indexed citations
5.
Kalbhen, D.A., et al.. (1993). Histomorphological Studies on the Effect of Recombinant Human Superoxide Dismutase in Biochemically Induced Osteoarthritis. Pharmacology. 47(4). 252–260. 6 indexed citations
6.
Dunham, Jane, et al.. (1993). Prolonged effect of iodoacetate on articular cartilage and its modification by an anti-rheumatic drug.. PubMed. 74(3). 283–9. 29 indexed citations
7.
8.
Steinmeyer, Jürgen & D.A. Kalbhen. (1991). Influence of some natural and semisynthetic agents on elastase and cathepsin G from polymorphonuclear granulocytes.. PubMed. 41(1). 77–80. 4 indexed citations
9.
Kalbhen, D.A. & Gerrit Jansen. (1990). [Pharmacologic studies on the antidegenerative effect of ademetionine in experimental arthritis in animals].. PubMed. 40(9). 1017–21. 2 indexed citations
10.
Kalbhen, D.A.. (1988). The Influence of NSAIDs on Morphology of Articular Cartilage. Scandinavian Journal of Rheumatology. 18(sup77). 13–22. 15 indexed citations
11.
Kalbhen, D.A.. (1982). [Chondroprotective and antiarthrotic properties of glycosaminoglycan polysulfate (GAGPS) in gonarthrosis in animal experiments].. PubMed. 41(5). 219–29. 5 indexed citations
12.
Kalbhen, D.A.. (1981). Zur Pharmakotherapie der Arthrosen. VS Verlag für Sozialwissenschaften eBooks. 1 indexed citations
13.
14.
Kalbhen, D.A. & Wolfgang B. Fischer. (1973). [Pharmacologic studies on the anti-inflammatory effect of pentosan polysulfate (SP 54) in combination with other analgesic or antiphlogistic agents].. PubMed. 23(5). 712–8. 1 indexed citations
15.
Kalbhen, D.A.. (1971). Nutmeg as a Narcotic. A Contribution to the Chemistry and Pharmacology of Nutmeg (Myristica fragrans). Angewandte Chemie International Edition in English. 10(6). 370–374. 24 indexed citations
16.
Kalbhen, D.A.. (1971). Die Muskatnuß als Rauschdroge Ein Beitrag zur Chemie und Pharmakologie der Muskatnuß (Myristica fragrans). Angewandte Chemie. 83(11). 392–396. 5 indexed citations
17.
Bohn, Robert K. & D.A. Kalbhen. (1971). Vergleichende untersuchungen über analytische verfahren zur auftrennung saurer mucopolysaccharide. Journal of Chromatography A. 62(3). 399–408. 5 indexed citations
18.
Kalbhen, D.A., et al.. (1970). Effects of natural and semisynthetic polysaccharides on connective tissue metabolism.. PubMed. 20(10). 1479–82. 4 indexed citations
19.
Kalbhen, D.A., et al.. (1968). A High Molecular Mucopolysaccharide Peptide Complex Stimulating Connective Tissue Metabolism. Pharmacology. 1(1). 33–42. 4 indexed citations
20.
Kalbhen, D.A., et al.. (1967). Methodische Untersuchungen zur quantitativen Mikrobestimmung von ATP in biologischem Material mit dem Firefly-Enzymsystem. Clinical Chemistry and Laboratory Medicine (CCLM). 5(6). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Domenjoz Breakdown of academic impact, for papers by Stephen R. Gross Breakdown of academic impact, for papers by A. Blackham Breakdown of academic impact, for papers by Lawrence W. Chakrin Breakdown of academic impact, for papers by M. Petríková Breakdown of academic impact, for papers by Anne‐Marie Lamhonwah Breakdown of academic impact, for papers by E A Burgess Breakdown of academic impact, for papers by Hiromi Sugimoto Breakdown of academic impact, for papers by Takashi Nose Breakdown of academic impact, for papers by F D Assimacopoulos-Jeannet
Rankless by CCL
2026